$24.50
+0.70 (+2.94%)
Open$24.43
Previous Close$23.80
Day High$25.49
Day Low$23.50
52W High$33.20
52W Low$13.89
Volume—
Avg Volume366.3K
Market Cap810.41M
P/E Ratio—
EPS$-3.22
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+209.4% upside
Current
$24.50
$24.50
Target
$75.80
$75.80
$52.19
$75.80 avg
$91.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.30M | 78.02M | 75.69M |
| Net Income | -75,738,911 | -16,723,517 | -20,379,208 |
| Profit Margin | -529.8% | -21.4% | -26.9% |
| EBITDA | -77,865,832 | -28,105,243 | -27,281,553 |
| Free Cash Flow | — | -11,355,754 | -12,035,038 |
| Rev Growth | — | -7.7% | +21.3% |
| Debt/Equity | 0.00 | 0.34 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |